head and neck cancer

ASCO ® Plenary Series
April 18, 2022 · Greg Guthrie, ASCO staff
Read research from the April 2022 session of the ASCO Plenary Series, which highlights a clinical trial that studied a medication called tislelizumab combined with chemotherapy to treat recurrent or metastatic nasopharyngeal cancer. Read More >>
April 14, 2022 · Perrin Romine, MD, and Kedar Kirtane, MD
Dr. Kedar Kirtane and Dr. Perrin Romine discuss the common sexual health concerns people with head and neck cancer have and how to get help with these concerns during and after cancer. Read More >>
March 31, 2022 · Brielle Gregory Collins, ASCO staff
In this podcast, Dr. Kedar Kirtane discusses research from the 2022 Multidisciplinary Head and Neck Cancers Symposium, including discussions around cancer disparities in head and neck cancer, treatment for HPV-positive oropharyngeal cancer, and strategies for treating HPV-related head and neck cancers. Read More >>
2021 ASCO Annual Meeting; #ASCO21
June 3, 2021 · ASCO Staff
The ASCO Annual Meeting begins on June 4, and here is some of the notable research that will be presented. Topics include combined immunotherapy for esophageal cancer, targeted radiation for mCRPC, olaparib for HER2-negative breast cancer, adjuvant chemotherapy for cervical cancer, pembrolizumab for kidney cancer, and toripalimab for nasopharyngeal cancer. Read More >>
April 21, 2021 · Eva Grayzel
Oral cancer survivor Eva Grayzel shares how her diagnosis gave her a new appreciation for words and how she changed the language she uses to embrace positivity after her voice returned. Read More >>

Pages